After a patient has a biopsy, the samples are sent to pathology to determine if it is cancerous or not as well as how aggressive it might be. Many patients will see their results before hearing from the medical team in their patient portal – leaving them anxious or confused on what it all means.

Pathologist, Dr. Cathyrn Lapedis, talks about the role of pathology in a patient’s care plan, as well as new ways to help patients when they get results before their physician is able go over to help them with anxiety and to be better informed about their potential diagnosis.

Participant:

Cathyrn Lapedis, MD

Resources:

People find medical tests hard to understand, increasing overall worry

Pathologists aid in patient understanding and quality of care

For more episodes, visit the Cancer Aware podcast website.

A transcript of this episode can be found here.

Cancer Aware is a part of the Michigan Medicine Podcast Network and is produced by the Michigan Medicine Department of Communication. You can listen to Cancer Aware wherever you get your podcasts.

Hosted on Acast. See acast.com/privacy for more information.

Those with an elevated prostate-specific antigen test are referred for a biopsy of their prostate to help diagnose prostate cancer or other prostate concerns. This can bring anxiety and discomfort for the patient.

Dr. Chad Ellimoottil, a urologist and division chief of men’s health and reconstruction at Michigan Medicine, shares information on prostate biopsies. He discusses those who need it, forms of biopsy, and the latest in performing them.

For more episodes, visit the Cancer Aware podcast website.

A transcript of this episode can be found here.

Participant

Chad Ellimoottil, MD

Additional Resources

Prostate-specific antigen test

Prostate cancer

Cancer Aware is a part of the Michigan Medicine Podcast Network and is produced by the Michigan Medicine Department of Communication. You can listen to Cancer Aware wherever you get your podcasts.

Hosted on Acast. See acast.com/privacy for more information.

When treating for localized prostate cancer, surgery and radiation are usually what people hear about. However, there are other treatments that could be options under a heading of focal therapy.

Dr. Andrew Wood, a urologic oncologist with the University of Michigan Health Rogel Cancer Center’s Weiser Center for Prostate Cancer talks about these options and which patients could benefit from them.

Participant

Andrew Wood, MD

You can learn more about Cancer Aware on our website.

A transcript of this episode can be found here.

Cancer Aware is a part of the Michigan Medicine Podcast Network and is produced by the Michigan Medicine Department of Communication. You can subscribe to Cancer Aware on Apple Podcasts, Spotify, or wherever you listen to podcasts.

Hosted on Acast. See acast.com/privacy for more information.